Amgen Inc.: A comprehensive report of the company's Information System

Alwasel, Athary A. . 2011
نوع عمل المنشور
Master Capstone Project
تاريخ المؤتمر
Quinnipiac University
ملخص المنشورات

Amgen Inc. is one of the world’s largest human therapeutics firms in the bio-technology industry. A Fortune 500 company that has exceled in the development of products based upon molecular biology and recombinant DNA, has drastically improved people’s lives by heavily investing into research and development, science, and innovation for over twenty-five years. The company has been well recognized for their achievements in delivering blockbuster medicines that the industry has never seen before. These blockbuster medicines have served millions of patients dedicated to helping them fight their battles with serious and life threatening illnesses. (About Amgen, 2011)
Amgen is arguably the fastest and one of the more successful Bio-Pharma companies in the world. They have achieved unparalleled growth and profitability in a short period of time. With this success, they have also suffered typical growing pains. Their support and systems infrastructure is barely able to keep up with the current demand. Additionally, the forecasted growth over the next couple of years makes a system upgrade not just important, but imperative if they are going to continue to support the business. Over the course of the next two years, Amgen is expected to have doubled in size from three years ago. The current business processes will not scale to that level and hence explains why an outside vendor was chosen to not only standardize the way in how their information systems support the business, but additionally help improve their current infrastructure to be able to withstand their future.
In this comprehensive research, not only will we discuss the information system strategy used to support their business needs and the challenges they face as an organization; we will also explain into detail about their technical architecture, the applications environment, and the data architecture that provisions the way this technology integrates with their business requirements. Additionally, this paper describes the enterprise architecture used in which we will explain into detail how this framework must align with the industry’s rules and regulations as strict laws must be followed and obeyed being that any organization in this field is regulated by the Food and Drug Administration (FDA) of the United States of America and the European Food Safety Authority (EFSA).